Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2-MedSci.cn

Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2

Li, CY; Fan, K; Qu, Y; Zhai, W; Huang, A; Sun, XF; Xing, SJ

Xing, SJ (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.

JOURNAL OF CELLULAR PHYSIOLOGY, 2020; 235 (4): 3721

Abstract

Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. As a platinum-based chemotherapeutic drug, cisplatin has been ......

Full Text Link